A

180 Life Sciences Corp

D
ATNF
USD
-0.12
(-5.8824%)
Market Closed
232.000
Volume
-3
EPS
-
Div Yield
-0.171428
P/E
1,971,705.60
Market Cap
Today
-5.8824%
1 Week
-4.000%
1 Month
1.587%
6 Months
-39.241%
12 Months
-84.744%
Year To Date
-53.773%
All Time
-99.948%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

EV Maker Fisker Files for Bankruptcy

18.06.2024
Stocks news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news

Tesla Sales Drop Amid Intensifying EV Competition

03.04.2024
Stocks news

EV Maker Fisker in Grave Trouble as Shares Tank

27.03.2024
Stocks news
More
Related Instruments
G
GBR
0
(0%)
USD
S
SOS
-0.0007
(-0.113%)
USD
B
BFRI
-0.01
(-0.7752%)
USD
C
CFMS
0.005
(0.2208%)
USD
S
SNDL
-0.02
(-0.9434%)
USD

Title:
180 Life Sciences Corp

Sector:
Healthcare
Industry:
Biotechnology
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate,combination therapy.
Do you need help or have a question?
Contact Us